Author: Himanshu Patni
17 February 2023
The vitamin K2 Market is expected to grow at a steady rate of around 25% during the forecast period. Vitamin K2 is naturally produced in human intestines by bacteria. The western diet is deficient in vitamin K2; hence pharmaceuticals and supplemental diets are required to provide vitamin K2. The market is expanding because of an expanding patient base with vitamin deficiencies, rising demand for products containing Vitamin K2, and rising cases of arthritis. For instance, according to the Centers for Disease Control and Prevention (CDC), around 1 in 4 US adults (23.7%) or about 58.5 million people have doctor-diagnosed arthritis.
Along with calcium and vitamin D, vitamin K2 may be an effective supplement for the treatment of osteoporosis that is toxic-free and comparable to bisphosphonate therapy. By reducing arterial calcification, it may also considerably reduce cardiovascular morbidity and mortality. In the cases of diabetes, cancer, and osteoarthritis, vitamin K2 appears promising. Although a dosage adjustment is necessary, the use of vitamin K during warfarin medication is safe and may help with INR (International Normalized Ratio) control.
For a detailed analysis of the Global Vitamin K2 Market browse through –https://univdatos.com/report/vitamin-k2-market/
Based on source, the market is segmented into natural and synthetic. Among them, synthetic category to witness higher CAGR during the forecast period. The high rate of production, an increase in vitamin deficiency disorders, increasing health awareness, and substantial economic expansion for nutritional supplements are the major factors for the growth of the vitamin K2 market.
On the basis of product, the market is categorized into MK-4, MK-7, and others. Among these, the MK-7 to hold a significant share in the market in 2020. This is mainly due to the growing usage of dietary supplements rising cases of coronary artery diseases because MK-7 based vitamins reduces the risk of coronary artery diseases, and vitamin K2 as MK-7, improves bone density by making blood vessels softer and bones harder.
Request for a sample of the report browse through- https://univdatos.com/get-a-free-sample-form-php/?product_id=33785
For a better understanding of the market adoption of the vitamin K2 industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the prevalence of effective medical facilities in nations like the United States and Canada, the rising use of herbal medicines, increasing healthcare expenditures, and the government’s emphasis on health and wellness. Moreover, the inclination toward living a healthy life is leasing to the growing consumption of supplements including vitamin K3 and the expansion of the food and beverage and cosmetic industries are the driving factors for the expansion of the regional market.
Some of the major players operating in the market include DSM, SEEBIO BIOTECH (SHANGHAI) CO., LTD., Viridis BioPharma Pvt. Ltd., Lesaffre, KYOWA HAKKO BIO CO. LTD., International Flavors & Fragrances Inc., GeneFerm Biotechnology Co. Ltd., DuPont, Kappa Bioscience, Vox Nutrition
Global Vitamin K2 Market Segmentation
Market Insight, by Source
· Natural
· Synthetic
Market Insight, by Product
· MK-4
· MK-7
· Others
Market Insight, by Application
· Pharmaceuticals
· Nutraceuticals & Food
· Others
Market Insight, by Region
· North America
o US
o Canada
o Rest of North America
· Europe
o Germany
o United Kingdom
o France
o Italy
o Spain
o Rest of Europe
· Asia-Pacific
o China
o Japan
o India
o Rest of Asia-Pacific
· Rest of the World
Top Company Profiles
· DSM
· SEEBIO BIOTECH (SHANGHAI) CO. LTD.
· Viridis BioPharma Pvt. Ltd.
· Lesaffre
· KYOWA HAKKO BIO CO. LTD.
· International Flavors & Fragrances Inc.
· GeneFerm Biotechnology Co. Ltd.
· DuPont
· Kappa Bioscience
· Vox Nutrition
Get a call back
